Table 2.

No. and percentage of patients at various doses of all three medication classes

	All without contraindication (n = 248)	Pre‐existing HF (n = 139)	De novo HF (n = 109)	P‐value
No. on any dose of all 3 medications	109 (44.0%)	68 (48.9%)	41 (37.6%)	0.08
No. at GAI50+ of all 3 medications	42 (16.9%)	24 (17.3%)	18 (16.5%)	0.88
No. at target doses of all 3 medications	3 (1.2%)	2 (1.4%)	1 (0.9%)	0.58

GAI50+, Guidelines Adherence Indicator 50+; HF, heart failure.